Morgan Stanley Balchem Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Balchem Corp stock. As of the latest transaction made, Morgan Stanley holds 862,618 shares of BCPC stock, worth $137 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

862,618

Previous 782,525 10.24%

Holding current value

$137 Million

Previous $130 Million 5.72%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$150.5 - $170.45 $12.1 Million - $13.7 Million	80,093 Added 10.24%	862,618 $137 Million
Q1 2025 May 15, 2025	SELL	$154.22 - $176.16 $1.85 Million - $2.11 Million	-11,974 Reduced 1.51%	782,525 $130 Million
Q4 2024 Feb 14, 2025	BUY	$163.0 - $183.41 $4.27 Million - $4.81 Million	26,212 Added 3.41%	794,499 $130 Million
Q3 2024 May 14, 2025	BUY	$154.1 - $181.56 $9.99 Million - $11.8 Million	64,827 Added 9.22%	768,287 $135 Million
Q3 2024 Nov 14, 2024	BUY	$154.1 - $181.56 $9.99 Million - $11.8 Million	64,827 Added 9.22%	768,287 $135 Million
Q2 2024 May 14, 2025	SELL	$138.5 - $156.63 $12.6 Million - $14.3 Million	-91,039 Reduced 11.46%	703,460 $108 Million
Q2 2024 Oct 17, 2024	BUY	$138.5 - $156.63 $23.3 Million - $26.3 Million	168,008 Added 31.38%	703,460 $108 Million
Q2 2024 Aug 14, 2024	BUY	$138.5 - $156.63 $23.3 Million - $26.3 Million	168,008 Added 31.38%	703,460 $108 Million
Q1 2024 Oct 17, 2024	SELL	$137.06 - $157.27 $23 Million - $26.4 Million	-168,008 Reduced 23.88%	535,452 $83 Million
Q1 2024 Aug 16, 2024	SELL	$137.06 - $157.27 $6.8 Million - $7.8 Million	-49,612 Reduced 8.48%	535,452 $83 Million
Q1 2024 May 15, 2024	SELL	$137.06 - $157.27 $6.8 Million - $7.8 Million	-49,612 Reduced 8.48%	535,452 $83 Million
Q4 2023 Aug 16, 2024	SELL	$115.08 - $150.35 $13.6 Million - $17.8 Million	-118,396 Reduced 16.83%	585,064 $87 Million
Q4 2023 Feb 13, 2024	BUY	$115.08 - $150.35 $6.7 Million - $8.75 Million	58,211 Added 11.05%	585,064 $87 Million
Q3 2023 Nov 15, 2023	SELL	$123.38 - $142.72 $737,442 - $853,037	-5,977 Reduced 1.12%	526,853 $65.4 Million
Q2 2023 Aug 14, 2023	BUY	$122.28 - $136.64 $6.17 Million - $6.89 Million	50,419 Added 10.45%	532,830 $71.8 Million
Q1 2023 May 15, 2023	SELL	$117.39 - $142.06 $1.07 Million - $1.29 Million	-9,095 Reduced 1.85%	482,411 $61 Million
Q4 2022 Feb 14, 2023	BUY	$120.16 - $142.73 $27.3 Million - $32.5 Million	227,360 Added 86.07%	491,506 $60 Million
Q3 2022 Nov 14, 2022	SELL	$119.7 - $141.48 $1.45 Million - $1.71 Million	-12,082 Reduced 4.37%	264,146 $32.1 Million
Q2 2022 Oct 27, 2022	BUY	$113.6 - $139.82 $12.2 Million - $15.1 Million	107,768 Added 63.97%	276,228 $35.8 Million
Q2 2022 Aug 15, 2022	BUY	$113.6 - $139.82 $12.2 Million - $15.1 Million	107,768 Added 63.97%	276,228 $35.8 Million
Q1 2022 Oct 27, 2022	SELL	$131.21 - $167.55 $14.1 Million - $18.1 Million	-107,768 Reduced 39.01%	168,460 $23 Million
Q1 2022 May 13, 2022	SELL	$131.21 - $167.55 $12,858 - $16,419	-98 Reduced 0.06%	168,460 $23 Million
Q4 2021 Feb 14, 2022	SELL	$149.18 - $172.5 $1.26 Million - $1.45 Million	-8,415 Reduced 4.75%	168,558 $28.4 Million
Q3 2021 Nov 15, 2021	BUY	$129.2 - $150.61 $22.9 Million - $26.7 Million	176,973 New	176,973 $25.7 Million

Others Institutions Holding BCPC

# of Institutions

421

Shares Held

28.6M

Call Options Held

64.8K

Put Options Held

6.2K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.09B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account